Connecting you to content on EBSCOhost

Works by Dehkohneh, Somayeh Ghadami

Results: 5

1

Heavy metal concentrations and clinical symptoms in patients diagnosed with schizophrenia related to cigarette smoking.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64333-9

By:

Ghaderi, Amir;
Khoshakhlagh, Amir Hossein;
Gruszecka-Kosowska, Agnieszka;
Askari-Lemjiri, Fatemeh;
Alemi, Fatemeh;
Molavi, Nader;
Hazegh, Pooya;
Farokhi, Bahareh;
Dehkohneh, Somayeh Ghadami;
Ghoreishi, Fatemeh Sadat

Publication type:

Article

2

Blood-lead level in humans and drug addiction: a comprehensive study in Iran.

Published in:

Environmental Science & Pollution Research, 2023, v. 30, n. 52, p. 112071, doi. 10.1007/s11356-023-30179-3

By:

Ghaderi, Amir;
Khoshakhlagh, Amir Hossein;
Gruszecka-Kosowska, Agnieszka;
Alemi, Fatemeh;
Hazegh, Pooya;
Aghaei, Zahra;
Molavi, Nader;
Mahdavi, Mojtaba;
Vahed, Neda;
Dehkohneh, Somayeh Ghadami;
Ostadmohammady, Fatemeh;
Das, Darpan

Publication type:

Article

3

Metabolic Syndrome Parameters in Psychiatric Disease: Current knowledge and Future Perspectives.

Published in:

International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 3, p. 1039, doi. 10.31838/ijpr/2020.12.03.157

By:

DEHKOHNEH, SOMAYEH GHADAMI;
AZADI, SARA;
RASOULI-AZAD, MORAD;
JALILIAN, JAFAR;
GHASEMINEGHAD, AZAM;
VAHED, NEDA;
RAZZAGHI, FARKHONDEH;
JAFARI, LEILA;
ABBASZADEH-MASHKANI, SAMIRA

Publication type:

Article

4

Oxidative Stress, Glycemic Control, Inflammation, and Lipid Profiles in Substance Abuse Disorders: Current Knowledge and Future Perspectives.

Published in:

International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 3, p. 1062, doi. 10.31838/ijpr/2020.12.03.158

By:

DEHKOHNEH, SOMAYEH GHADAMI;
AZADI, SARA;
RASOUALI-AZAD, MORAD;
JALILIAN, JAFAR;
GHASEMINEGHAD, AZAM;
VAHED, NEDA;
RAZZAGHI, FARKHONDEH;
ZAHIRY POUR, AMINEH SADAT;
JAFARI, LEILA;
ABBASZADEH-MASHKANI, SAMIRA

Publication type:

Article

5

The therapeutic effect of N‐acetylcysteine as an add‐on to methadone maintenance therapy medication in outpatients with substance use disorders: A randomized, double‐blind, placebo‐controlled clinical trial.

Published in:

Brain & Behavior, 2023, v. 13, n. 1, p. 1, doi. 10.1002/brb3.2823

By:

Padoei, Fateme;
Mamsharifi, Peyman;
Hazegh, Pooya;
Boroumand, Homa;
Ostadmohammady, Fatemeh;
Abbaszadeh‐Mashkani, Samira;
Banafshe, Hamid Reza;
Matini, Amir Hassan;
Ghaderi, Amir;
Dehkohneh, Somayeh Ghadami

Publication type:

Article